title: Inter-tumor heterogeneity.
abstract: Advances in the molecular study of cancer have focused on biomarkers in the setting of tumor-driving mutations within the great heterogeneity of the tumor genomic landscape. It is clearly recognized now that even two tumors originating from the same organ even if histological they appear similar their behavior and response to therapy can be different. These findings have increased interest and research to find truly prognostic and predictive biomarkers to serve as tools in better assessing the natural course of disease and response to treatments in the hope of truly individualizing cancer therapy in the future.
authors.affiliation: Mount Sinai Comprehensive Cancer Center, Miami Beach, FL USA. mike.cusnir@msmc.com
authors.forename: Mike
authors.initials: M
authors.lastname: Cusnir
authors.forename: Ludmila
authors.initials: L
authors.lastname: Cavalcante
mesh_terms: D014408:Biomarkers, Tumor; D014644:Genetic Variation; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor